Advertisement
Screener

INMUNE BIO INC. (INMB) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

INMUNE BIO INC. Cash Flow Breakdown

Cash flow breakdown shows where INMUNE BIO INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $22.58M went out.
  • Fiscal year ended 2025-12-31: from investing, $1.04M went out.
  • Fiscal year ended 2025-12-31: from financing, $27.61M came in.
  • Fiscal year ended 2025-12-31: change in cash, $3.83M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2025-12-31-$22.58M-$1.04M$27.54M$3.83M
2024-12-31-$33.36M-$10.00M$27.79M-$14.93M
2023-12-31-$11.98M-$5.00M$775.00K-$16.30M
2022-12-31-$22.69M$699.00K-$22.66M
2021-12-31-$28.50M-$15.00M$14.95M$80.25M$1.15M*$52.84M
2020-12-31-$8.94M$24.91M-$1.01M*$14.97M
2019-12-31-$5.38M$12.21M$6.81M
2018-12-31-$2.06M$900.00K-$1.18M
2017-12-31-$761.83K-$100.00K$2.06M$1.23M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2026-06-30-$3.17M*
2026-03-31-$3.40M-$3.39M
2025-12-31-$2.94M*-$143.00K*$0.00*
2025-09-30-$5.44M*-$193.00K*$0.00*
2025-06-30-$7.38M*$22.27M*
2025-03-31-$6.82M$5.27M-$1.58M
2024-12-31-$11.01M*-$2.50M*$0.00*
2024-09-30-$6.99M*-$2.50M*$12.29M*
2024-06-30-$7.89M*-$2.50M*$15.50M*
2024-03-31-$7.48M-$2.50M-$9.85M
2023-12-31-$3.40M*-$2.50M*$0.00*
2023-09-30-$4.26M*
2023-06-30-$3.17M*
2023-03-31-$1.14M-$1.15M
2022-12-31-$5.70M*$0.00*
2022-09-30-$3.37M*$0.00*
2022-06-30-$4.76M*$0.00*
2022-03-31-$8.87M$699.00K-$8.08M
2021-12-31-$9.78M*$0.00*$0.00*$0.00*-$9.66M*
2021-09-30-$7.92M*$0.00*$0.00*$51.81M*$1.14M*$44.95M*
2021-06-30-$5.71M*$0.00*$14.95M*-$5.82M*
2021-03-31-$5.09M$28.45M$23.37M
2020-12-31-$2.39M*$0.00*-$2.34M*
2020-09-30-$3.70M*$23.24M*$19.50M*
2020-06-30-$1.82M*$664.00K*-$1.11M*
2020-03-31-$1.03M$1.00M*-$1.06M
2019-12-31-$433.37K*$0.00*-$387.14K*
2019-09-30-$1.95M*$0.00*-$1.98M*
2019-06-30-$1.62M*$4.96M*$3.32M*
2019-03-31-$1.39M$7.25M$5.86M
2018-12-31-$462.38K*$0.00*-$464.66K*
2018-09-30-$449.93K*$0.00*-$457.55K*
2018-06-30-$817.85K*$0.00*-$847.89K*
2018-03-31-$328.84K$900.00K$585.59K

Similar stocks

Stock NameCountryMarket CapPE Ratio
ImageneBio, Inc. (IMA)United States$0.056B-1.31
BioAtla, Inc. (BCAB)United States$0.058B-0.21
EXOZYMES INC. (EXOZ)United States$0.058B
Tevogen Inc. (TVGN)United States$0.049B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Instil Bio, Inc. (TIL)United States$0.048B-1.73
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
BioStem Technologies, Inc. (BSEM)United States$0.069B